Last 12 months
Inside the activity.
11 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 4 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 5 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2026 Filed Mar 4, 2026 00:15 UTC |
VanHimbergen Robert MEVP and CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 48,375 | $0.00 Strike: $26.40 | $0.00 |
DisclosureSEC source: 0001724169-26-000010 · form4-03042026_120351.xml · derivative · entry 2 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,375 Underlying: Common Stock · 48,375 shares Expires 2036-03-01 F3 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:15 UTC |
VanHimbergen Robert MEVP and CFO
|
GrantCommon Stock | 23,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001724169-26-000010 · form4-03042026_120351.xml · nonDerivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,652 F1 · shares: Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. F2 · balance_after: Includes 744 shares acquired under Elanco Animal Health Inc.'s Employee Stock Purchase Plan on January 31, 2026. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:18 UTC |
Simmons Jeffrey NDirector · PRESIDENT, CEO AND DIRECTOR
|
GrantDeferred Stock Units (Match) · Derivative | 6,593 | $0.00 | $0.00 |
DisclosureSEC source: 0001479079-26-000011 · form4-03042026_120334.xml · derivative · entry 6 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,593 Underlying: Common Stock · 6,593 shares Expires not disclosed F4 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F5 · derivative.exercise_date: Deferred stock units vest December 31, 2027 and settle upon termination of employment or otherwise in accordance with the Executive Deferral and Stock Match Plan. F5 · derivative.expiration_date: Deferred stock units vest December 31, 2027 and settle upon termination of employment or otherwise in accordance with the Executive Deferral and Stock Match Plan. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:18 UTC |
Simmons Jeffrey NDirector · PRESIDENT, CEO AND DIRECTOR
|
GrantEmployee Stock Option (right to buy) · Derivative | 243,809 | $0.00 Strike: $26.40 | $0.00 |
DisclosureSEC source: 0001479079-26-000011 · form4-03042026_120334.xml · derivative · entry 5 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,809 Underlying: Common Stock · 243,809 shares Expires 2036-03-01 F3 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:18 UTC |
Simmons Jeffrey NDirector · PRESIDENT, CEO AND DIRECTOR
|
GrantCommon Stock | 119,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001479079-26-000011 · form4-03042026_120334.xml · nonDerivative · entry 3 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,089,796 F2 · shares: Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:18 UTC |
Simmons Jeffrey NDirector · PRESIDENT, CEO AND DIRECTOR
|
Tax withholdingCommon Stock | 229,982 | $26.40 | $6,071,524.80 |
DisclosureSEC source: 0001479079-26-000011 · form4-03042026_120334.xml · nonDerivative · entry 2 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,970,477 Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:18 UTC |
Simmons Jeffrey NDirector · PRESIDENT, CEO AND DIRECTOR
|
GrantCommon Stock | 397,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001479079-26-000011 · form4-03042026_120334.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,200,459 F1 · balance_after: Includes 1,038 shares acquired on January 31, 2026 under Elanco Animal Health Inc.'s Employee Stock Purchase Plan. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:19 UTC |
Meer James MCHIEF ACCOUNTING OFFICER
|
GrantCommon Stock | 5,209 | $0.00 | $0.00 |
DisclosureSEC source: 0001754243-26-000002 · form4-03042026_120332.xml · nonDerivative · entry 3 Meer James M · CIK 0001754243 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,121 F1 · shares: Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:19 UTC |
Meer James MCHIEF ACCOUNTING OFFICER
|
Tax withholdingCommon Stock | 4,787 | $26.40 | $126,376.80 |
DisclosureSEC source: 0001754243-26-000002 · form4-03042026_120332.xml · nonDerivative · entry 2 Meer James M · CIK 0001754243 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,912 Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:19 UTC |
Meer James MCHIEF ACCOUNTING OFFICER
|
GrantCommon Stock | 9,596 | $0.00 | $0.00 |
DisclosureSEC source: 0001754243-26-000002 · form4-03042026_120332.xml · nonDerivative · entry 1 Meer James M · CIK 0001754243 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,699 Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:19 UTC |
Modi Rajeev A.SEE REMARKS
|
GrantDeferred Stock Units (Match) · Derivative | 2,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001916473-26-000010 · form4-03042026_120303.xml · derivative · entry 5 Modi Rajeev A. · CIK 0001916473 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,532 Underlying: Common Stock · 2,532 shares Expires not disclosed F4 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F5 · derivative.exercise_date: Deferred stock units vest December 31, 2027 and settle upon termination of employment or otherwise in accordance with the Executive Deferral and Stock Match Plan. F5 · derivative.expiration_date: Deferred stock units vest December 31, 2027 and settle upon termination of employment or otherwise in accordance with the Executive Deferral and Stock Match Plan. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:19 UTC |
Modi Rajeev A.SEE REMARKS
|
GrantEmployee Stock Option (right to buy) · Derivative | 29,025 | $0.00 Strike: $26.40 | $0.00 |
DisclosureSEC source: 0001916473-26-000010 · form4-03042026_120303.xml · derivative · entry 4 Modi Rajeev A. · CIK 0001916473 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,025 Underlying: Common Stock · 29,025 shares Expires 2036-03-01 F3 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:19 UTC |
Modi Rajeev A.SEE REMARKS
|
GrantCommon Stock | 14,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001916473-26-000010 · form4-03042026_120303.xml · nonDerivative · entry 3 Modi Rajeev A. · CIK 0001916473 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,293 F2 · shares: Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:19 UTC |
Modi Rajeev A.SEE REMARKS
|
Tax withholdingCommon Stock | 19,375 | $26.40 | $511,500.00 |
DisclosureSEC source: 0001916473-26-000010 · form4-03042026_120303.xml · nonDerivative · entry 2 Modi Rajeev A. · CIK 0001916473 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,088 Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:19 UTC |
Modi Rajeev A.SEE REMARKS
|
GrantCommon Stock | 41,690 | $0.00 | $0.00 |
DisclosureSEC source: 0001916473-26-000010 · form4-03042026_120303.xml · nonDerivative · entry 1 Modi Rajeev A. · CIK 0001916473 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,463 F1 · balance_after: Includes 691 shares acquired on January 31, 2026 under Elanco Animal Health Inc.'s Employee Stock Purchase Plan Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:17 UTC |
Cabral Ramiro MartinSEE REMARKS
|
GrantEmployee Stock Option (right to buy) · Derivative | 42,570 | $0.00 Strike: $26.40 | $0.00 |
DisclosureSEC source: 0001752437-26-000002 · form4-03042026_120338.xml · derivative · entry 4 Cabral Ramiro Martin · CIK 0001752437 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,570 Underlying: Common Stock · 42,570 shares Expires 2036-03-01 F2 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:17 UTC |
Cabral Ramiro MartinSEE REMARKS
|
GrantCommon Stock | 20,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001752437-26-000002 · form4-03042026_120338.xml · nonDerivative · entry 3 Cabral Ramiro Martin · CIK 0001752437 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 290,366 F1 · shares: Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:17 UTC |
Cabral Ramiro MartinSEE REMARKS
|
Tax withholdingCommon Stock | 30,150 | $26.40 | $795,960.00 |
DisclosureSEC source: 0001752437-26-000002 · form4-03042026_120338.xml · nonDerivative · entry 2 Cabral Ramiro Martin · CIK 0001752437 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 269,532 Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:17 UTC |
Cabral Ramiro MartinSEE REMARKS
|
GrantCommon Stock | 60,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001752437-26-000002 · form4-03042026_120338.xml · nonDerivative · entry 1 Cabral Ramiro Martin · CIK 0001752437 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 299,682 Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:17 UTC |
McArdle GraceEVP, MANUFACTURING AND QUALITY
|
GrantEmployee Stock Option (right to buy) · Derivative | 29,025 | $0.00 Strike: $26.40 | $0.00 |
DisclosureSEC source: 0001982573-26-000002 · form4-03042026_120308.xml · derivative · entry 4 McArdle Grace · CIK 0001982573 · EVP, MANUFACTURING AND QUALITY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,025 Underlying: Common Stock · 29,025 shares Expires 2036-03-01 F2 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:17 UTC |
McArdle GraceEVP, MANUFACTURING AND QUALITY
|
GrantCommon Stock | 14,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001982573-26-000002 · form4-03042026_120308.xml · nonDerivative · entry 3 McArdle Grace · CIK 0001982573 · EVP, MANUFACTURING AND QUALITY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,027 F1 · shares: Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:17 UTC |
McArdle GraceEVP, MANUFACTURING AND QUALITY
|
Tax withholdingCommon Stock | 12,337 | $26.40 | $325,696.80 |
DisclosureSEC source: 0001982573-26-000002 · form4-03042026_120308.xml · nonDerivative · entry 2 McArdle Grace · CIK 0001982573 · EVP, MANUFACTURING AND QUALITY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,822 Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:17 UTC |
McArdle GraceEVP, MANUFACTURING AND QUALITY
|
GrantCommon Stock | 30,110 | $0.00 | $0.00 |
DisclosureSEC source: 0001982573-26-000002 · form4-03042026_120308.xml · nonDerivative · entry 1 McArdle Grace · CIK 0001982573 · EVP, MANUFACTURING AND QUALITY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,159 Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:14 UTC |
de Brabander EllenSEE REMARKS
|
GrantEmployee Stock Option (right to buy) · Derivative | 51,819 | $0.00 Strike: $26.40 | $0.00 |
DisclosureSEC source: 0001892179-26-000002 · form4-03042026_120344.xml · derivative · entry 4 de Brabander Ellen · CIK 0001892179 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,819 Underlying: Common Stock · 51,819 shares Expires 2036-03-01 F2 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:14 UTC |
de Brabander EllenSEE REMARKS
|
GrantCommon Stock | 25,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001892179-26-000002 · form4-03042026_120344.xml · nonDerivative · entry 3 de Brabander Ellen · CIK 0001892179 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 268,386 F1 · shares: Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:14 UTC |
de Brabander EllenSEE REMARKS
|
Tax withholdingCommon Stock | 46,278 | $26.40 | $1,221,739.20 |
DisclosureSEC source: 0001892179-26-000002 · form4-03042026_120344.xml · nonDerivative · entry 2 de Brabander Ellen · CIK 0001892179 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,026 Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:14 UTC |
de Brabander EllenSEE REMARKS
|
GrantCommon Stock | 67,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001892179-26-000002 · form4-03042026_120344.xml · nonDerivative · entry 1 de Brabander Ellen · CIK 0001892179 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 289,304 Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:15 UTC |
O'Neill ShivGC AND CORP SEC
|
GrantEmployee Stock Option (right to buy) · Derivative | 29,993 | $0.00 Strike: $26.40 | $0.00 |
DisclosureSEC source: 0002001171-26-000002 · form4-03042026_120323.xml · derivative · entry 4 O'Neill Shiv · CIK 0002001171 · GC AND CORP SEC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,993 Underlying: Common Stock · 29,993 shares Expires 2036-03-01 F2 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:15 UTC |
O'Neill ShivGC AND CORP SEC
|
GrantCommon Stock | 14,679 | $0.00 | $0.00 |
DisclosureSEC source: 0002001171-26-000002 · form4-03042026_120323.xml · nonDerivative · entry 3 O'Neill Shiv · CIK 0002001171 · GC AND CORP SEC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,572 F1 · shares: Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:15 UTC |
O'Neill ShivGC AND CORP SEC
|
Tax withholdingCommon Stock | 13,111 | $26.40 | $346,130.40 |
DisclosureSEC source: 0002001171-26-000002 · form4-03042026_120323.xml · nonDerivative · entry 2 O'Neill Shiv · CIK 0002001171 · GC AND CORP SEC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,893 Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:15 UTC |
O'Neill ShivGC AND CORP SEC
|
GrantCommon Stock | 33,087 | $0.00 | $0.00 |
DisclosureSEC source: 0002001171-26-000002 · form4-03042026_120323.xml · nonDerivative · entry 1 O'Neill Shiv · CIK 0002001171 · GC AND CORP SEC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,004 Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:13 UTC |
Bettington Timothy JSEE REMARKS
|
GrantEmployee Stock Option (right to buy) · Derivative | 19,350 | $0.00 Strike: $24.60 | $0.00 |
DisclosureSEC source: 0001797894-26-000002 · form4-03042026_120312.xml · derivative · entry 4 Bettington Timothy J · CIK 0001797894 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,350 Underlying: Common Stock · 19,350 shares Expires 2036-03-01 F2 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:13 UTC |
Bettington Timothy JSEE REMARKS
|
GrantCommon Stock | 9,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001797894-26-000002 · form4-03042026_120312.xml · nonDerivative · entry 3 Bettington Timothy J · CIK 0001797894 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,956 F1 · shares: Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:13 UTC |
Bettington Timothy JSEE REMARKS
|
Tax withholdingCommon Stock | 18,098 | $26.40 | $477,787.20 |
DisclosureSEC source: 0001797894-26-000002 · form4-03042026_120312.xml · nonDerivative · entry 2 Bettington Timothy J · CIK 0001797894 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,486 Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:13 UTC |
Bettington Timothy JSEE REMARKS
|
GrantCommon Stock | 46,322 | $0.00 | $0.00 |
DisclosureSEC source: 0001797894-26-000002 · form4-03042026_120312.xml · nonDerivative · entry 1 Bettington Timothy J · CIK 0001797894 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,584 Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 21:43 UTC |
VanHimbergen Robert MEVP and CFO
|
GrantDeferred Stock Units · Derivative | 7.6217 | $24.98 | $190.39 |
DisclosureSEC source: 0001724169-26-000008 · form4-02242026_090213.xml · derivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31.0919 Underlying: Common Stock · 7.6217 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 21:44 UTC |
Simmons Jeffrey NDirector · PRESIDENT, CEO AND DIRECTOR
|
GrantDeferred Stock Units · Derivative | 110.8583 | $24.98 | $2,769.24 |
DisclosureSEC source: 0001479079-26-000009 · form4-02242026_090216.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,179.7639 Underlying: Common Stock · 110.8583 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 21:45 UTC |
Modi Rajeev A.SEE REMARKS
|
GrantDeferred Stock Units · Derivative | 56.6301 | $24.98 | $1,414.62 |
DisclosureSEC source: 0001916473-26-000008 · form4-02242026_090202.xml · derivative · entry 1 Modi Rajeev A. · CIK 0001916473 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,651.0914 Underlying: Common Stock · 56.6301 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:33 UTC |
VanHimbergen Robert MEVP and CFO
|
GrantDeferred Stock Units · Derivative | 7.5552 | $25.20 | $190.39 |
DisclosureSEC source: 0001724169-26-000006 · form4-02102026_090227.xml · derivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23.4702 Underlying: Common Stock · 7.5552 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:32 UTC |
Simmons Jeffrey NDirector · PRESIDENT, CEO AND DIRECTOR
|
GrantDeferred Stock Units · Derivative | 109.8905 | $25.20 | $2,769.24 |
DisclosureSEC source: 0001479079-26-000007 · form4-02102026_090248.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,068.9056 Underlying: Common Stock · 109.8905 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:32 UTC |
Modi Rajeev A.SEE REMARKS
|
GrantDeferred Stock Units · Derivative | 56.1357 | $25.20 | $1,414.62 |
DisclosureSEC source: 0001916473-26-000006 · form4-02102026_090217.xml · derivative · entry 1 Modi Rajeev A. · CIK 0001916473 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,594.4613 Underlying: Common Stock · 56.1357 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 21:27 UTC |
VanHimbergen Robert MEVP and CFO
|
GrantDeferred Stock Units · Derivative | 7.8029 | $24.40 | $190.39 |
DisclosureSEC source: 0001724169-26-000004 · form4-01272026_090118.xml · derivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15.915 Underlying: Common Stock · 7.8029 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 21:28 UTC |
Simmons Jeffrey NDirector · PRESIDENT, CEO AND DIRECTOR
|
GrantDeferred Stock Units · Derivative | 113.4934 | $24.40 | $2,769.24 |
DisclosureSEC source: 0001479079-26-000005 · form4-01272026_090113.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,959.0151 Underlying: Common Stock · 113.4934 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 21:27 UTC |
Modi Rajeev A.SEE REMARKS
|
GrantDeferred Stock Units · Derivative | 57.9762 | $24.40 | $1,414.62 |
DisclosureSEC source: 0001916473-26-000004 · form4-01272026_090144.xml · derivative · entry 1 Modi Rajeev A. · CIK 0001916473 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,538.3256 Underlying: Common Stock · 57.9762 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| January 09, 2026 Filed Jan 13, 2026 23:10 UTC |
VanHimbergen Robert MEVP and CFO
|
GrantDeferred Stock Units · Derivative | 8.1121 | $23.47 | $190.39 |
DisclosureSEC source: 0001724169-26-000002 · form4-01132026_110106.xml · derivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8.1121 Underlying: Common Stock · 8.1121 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| January 09, 2026 Filed Jan 13, 2026 23:09 UTC |
Simmons Jeffrey NDirector · PRESIDENT, CEO AND DIRECTOR
|
GrantDeferred Stock Units · Derivative | 117.9906 | $23.47 | $2,769.24 |
DisclosureSEC source: 0001479079-26-000003 · form4-01132026_110108.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,845.5217 Underlying: Common Stock · 117.9906 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| January 09, 2026 Filed Jan 13, 2026 23:10 UTC |
Modi Rajeev A.SEE REMARKS
|
GrantDeferred Stock Units · Derivative | 60.2735 | $23.47 | $1,414.62 |
DisclosureSEC source: 0001916473-26-000002 · form4-01132026_110139.xml · derivative · entry 1 Modi Rajeev A. · CIK 0001916473 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,480.3494 Underlying: Common Stock · 60.2735 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 22:35 UTC |
Anand Kapila KDirector
|
GrantDeferred Stock Units · Derivative | 381.1312 | $22.63 | $8,625.00 |
DisclosureSEC source: 0001679166-26-000002 · form4-01052026_100159.xml · derivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,894.7414 Underlying: Common Stock · 381.1312 shares Expires not disclosed F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $22.63 on December 31, 2025. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $22.63 on December 31, 2025. F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| December 26, 2025 Filed Dec 30, 2025 21:16 UTC |
Simmons Jeffrey NDirector · PRESIDENT, CEO AND DIRECTOR
|
GrantDeferred Stock Units · Derivative | 122.5327 | $22.60 | $2,769.24 |
DisclosureSEC source: 0001479079-25-000021 · form4-12302025_091245.xml · derivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · Director · PRESIDENT, CEO AND DIRECTOR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,727.5311 Underlying: Common Stock · 122.5327 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| December 26, 2025 Filed Dec 30, 2025 21:16 UTC |
Modi Rajeev A.SEE REMARKS
|
GrantDeferred Stock Units · Derivative | 62.5938 | $22.60 | $1,414.62 |
DisclosureSEC source: 0001916473-25-000021 · form4-12302025_091201.xml · derivative · entry 1 Modi Rajeev A. · CIK 0001916473 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,420.0759 Underlying: Common Stock · 62.5938 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.